Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 129 - 136 of 11616 results
Federal Trade Commission Finalizes HSR Changes
October 11, 2024| Alert| Viewpoint
‘A Pro Bono Pioneer’
October 11, 2024| News
F-Reorgs: How Buyers’ and Sellers’ Favorite ‘F Word’ Optimizes M&A and Private Equity Transactions Involving S Corporations
October 10, 2024| Alert| Viewpoint
'Spycraft' by Employers Raising Alarm as Technology Advances
October 10, 2024| News
Plaintiff's Non-compete Play 'Gives Pro-business Fans Reason to Celebrate'
October 10, 2024| News
Private Equity: How to Stay Out of the DOJ’s Cross-Hairs
October 10, 2024| News
In-House Leaders Trying to Contain Political Divisiveness Face Maze of Challenges
October 10, 2024| News
Contemplating the Impact of the USPTO’s AI-Focused Patent Eligibility Guidance on Networking Applications
October 9, 2024| Blog| Viewpoint
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.